Drug · DIN 02553716
FLUCELVAX
MULTIDOSE VIAL
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since December 3, 2024.
- Drug Identification Number (DIN)
- 02553716
- Company (DIN owner)
- Seqirus Uk LimitedMaidenhead, Berkshire, United Kingdom
- Schedule
- Schedule d
- Dosage form
- Suspension
- Route
- Intramuscular
- Therapeutic class (ATC)
- Influenza, inactivated, split virus or surface antigen J07BB02
- Class
- Human
- Record last updated
- September 28, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HAEMAGGLUTININ-STRAIN A (H1N1) | 15 MCG | 0.5 ML |
| HAEMAGGLUTININ-STRAIN A (H3N2) | 15 MCG | 0.5 ML |
| HAEMAGGLUTININ-STRAIN B | 15 MCG | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 3, 2024: NOC 34507New Drug Submission (NDS)
Other DINs named FLUCELVAX
- DIN 02553708 · Marketed